the 28-day representations period and the CHM letter mechanism, applies only to applications submitted on or after April 3, 2025. The DCVax-L MAA review began on April 1, 2024, so it falls under the previous procedure, in which there was no formal requirement for a CHM letter or a 28-day representations period.
....
Additionally, LP (as a lawyer), had she been in possession of a 28 day letter citing a CHM recommendation to deny the MA would never have said at the 12/29/25 ASM statements such as she made:
Can you clarify whether you are agreeing or disagreeing with Flipper in his post #805994? Same question in reverse to Flipper.